These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31585174)
1. Reporting of randomized factorial trials was frequently inadequate. Kahan BC; Tsui M; Jairath V; Scott AM; Altman DG; Beller E; Elbourne D J Clin Epidemiol; 2020 Jan; 117():52-59. PubMed ID: 31585174 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Analysis and reporting of factorial trials: a systematic review. McAlister FA; Straus SE; Sackett DL; Altman DG JAMA; 2003 May; 289(19):2545-53. PubMed ID: 12759326 [TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
5. Reporting of factorial trials of complex interventions in community settings: a systematic review. Montgomery AA; Astin MP; Peters TJ Trials; 2011 Jul; 12():179. PubMed ID: 21771302 [TBL] [Abstract][Full Text] [Related]
9. Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions? Freidlin B; Korn EL J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954288 [TBL] [Abstract][Full Text] [Related]
10. An examination of effect estimation in factorial and standardly-tailored designs. Allore HG; Murphy TE Clin Trials; 2008; 5(2):121-30. PubMed ID: 18375650 [TBL] [Abstract][Full Text] [Related]
11. Designs for efficient clinical trials. Simon R Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811 [TBL] [Abstract][Full Text] [Related]
15. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials. Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516 [TBL] [Abstract][Full Text] [Related]
16. Factorial designs in clinical trials: the effects of non-compliance and subadditivity. Brittain E; Wittes J Stat Med; 1989 Feb; 8(2):161-71. PubMed ID: 2704898 [TBL] [Abstract][Full Text] [Related]
17. Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. Smyth RM; Kirkham JJ; Jacoby A; Altman DG; Gamble C; Williamson PR BMJ; 2011 Jan; 342():c7153. PubMed ID: 21212122 [TBL] [Abstract][Full Text] [Related]
18. Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial. Haviari S; Mentré F BMC Med Res Methodol; 2024 Mar; 24(1):64. PubMed ID: 38468221 [TBL] [Abstract][Full Text] [Related]
19. Trial designs for evaluating combination HIV prevention approaches. Chen YQ; Peng L; Wang Y; Appelmans E; Dasgupta S; Fleming TR HIV Res Clin Pract; 2020; 21(2-3):72-82. PubMed ID: 32698705 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of intervention reporting in published emergency medicine clinical trials. Fladie IA; Rorah D; Pollard J; Jellison S; Thabane L; Murray K; Gardner G; Vassar M Am J Emerg Med; 2020 Jun; 38(6):1171-1177. PubMed ID: 32340822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]